Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
This guide reviews criteria to determine the best cheap dividend ETF, including cost structure, track record, and diversification benefits for investors.
22,413 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
Summit Funding plans large-scale layoffs as CrossCountry Mortgage advances its acquisition. About 163 employees will ...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
The U.S. Postal Service has filed for an 8% temporary price increase on Priority Mail and other core services to offs...
Harvey, an AI-driven legal tech startup, has surged to an $11 billion valuation after attracting OpenAI backing. The ...
This analysis dives into worksport (wksp) 2025 earnings, decoding the Q4 2025 transcript. Learn how revenue, margins,...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Unity Software’s latest guidance sparked a sharp rally, underscoring how Vector AI could redefine monetization in int...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...